Serum 25-Hydroxyvitamin D: A predictor of macrovascular and microvascular complications in patients with type 2 diabetes

Diabetes Care

Volumn 38, Issue 3, 2015, Pages 521-528

  Herrmann, Markus ^a   Sullivan, David R ^a   Veillard, Anne Sophie ^b   McCorquodale, Thomas ^a   Straub, Isabella R ^a   Scott, Russell ^c   Laakso, Markku ^d   Topliss, Duncan ^e   Jenkins, Alicia J ^b   Blankenberg, Stefan ^f   Burton, Anthony ^g   Keech, Anthony C ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY HEART CENTER HAMBURG   (Germany)

^g FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; AMPUTATION; ARTICLE; AUSTRALIA; BLOOD SAMPLING; CEREBROVASCULAR ACCIDENT; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; FINLAND; HEART INFARCTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEASONAL VARIATION; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; INCIDENCE; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL MODEL; STROKE; VITAMIN D DEFICIENCY;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK; STROKE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84933043044     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0180     Document Type: Article

References (43)

1. World Health Organization. 10 facts about diabetes [article online], 2013. Available from http://www.who.int/features/factfiles/diabetes/en/Accessed May 2013.
2. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and allcause mortality in older U.S. adults. J Am Geriatr Soc 2009;57:1595-1603.
3. Scragg R. Vitamin D and cardiovascular disease: A review of the epidemiological and clinical evidence. In Vitamins in the Prevention of Human Diseases. Herrmann W, Obeid R, Eds. Berlin, de Gruyter, 2011, p. 409-426.
4. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25- hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008;168:1174-1180.
5. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009;205: 255-260.
6. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-2029.
7. Palomer X, Gonźalez-Clemente JM, Blanco- Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-197.
8. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010;39:419-446.
9. Keech AC, Mitchell P, Summanen PA, et al.; FIELD study investigators. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): A randomised controlled trial. Lancet 2007;370:1687-1697.
10. Keech A, Simes RJ, Barter P, et al.; FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet 2005;366:1849-1861.
11. Davis TM, Ting R, Best JD, et al.; Fenofibrate Intervention and Event Lowering in Diabetes Study investigators. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia 2011;54:280-290.
12. FIELD Study Investigators. The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Cardiovasc Diabetol 2004;3:9.
13. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: A comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012;58:531- 542.
14. Valcour A, Blocki F, Hawkins DM, Rao SD. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab 2012;97:3989-3995.
15. Rankin SL, Briffa TG, Morton AR, Hung J. A specific activity questionnaire to measure the functional capacity of cardiac patients. Am J Cardiol 1996;77:1220-1223.
16. Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA. Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? Diabet Med 2012;29:43-49.
17. Payne JF, Ray R, Watson DG, et al. Vitamin D Insufficiency in Diabetic Retinopathy. Endocr Pract 2012;18:185-193.
18. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007;71:134-139.
19. Soderstrom LH, Johnson SP, Diaz VA, Mainous AG 3rd. Association between vitamin D and diabetic neuropathy in a nationally representative sample: Results from 2001-2004 NHANES. Diabet Med 2012;29:50-55.
20. Kaur H, Donaghue KC, Chan AK, et al. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care 2011;34:1400-1402.
21. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980;209:823-825.
22. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986;119:84-90.
23. Billaudel BJ, Faure AG, Sutter BC. Effect of 1, 25 dihydroxyvitamin D3 on isolated islets from vitamin D3-deprived rats. Am J Physiol 1990; 258:E643-E648.
24. Borges MC, Martini LA, Rogero MM. Current perspectives on vitamin D, immune system, and chronic diseases. Nutrition 2011;27:399-404.
25. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol 2014;2:76-89.
26. Theodoratou E, Tzoulaki I, Zgaga L, Ionnadis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and metanalyses of observational studies and randomised trials. BMJ 2014;348:g2035.
27. Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903.
28. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011;7:CD007470.
29. Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev Endocr Metab Disord 2012;13:71-77.
30. Ceglia L, Harris SS. Vitamin D and its role in skeletal muscle. Calcif Tissue Int 2013;92:151- 162.
31. Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 2013;34:33-83.
32. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009;94:4023-4030.
33. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008;25:320-325.
34. Weishaar RE, Simpson RU. Vitamin D3 and cardiovascular function in rats. J Clin Invest 1987;79:1706-1712.
35. Wang Y, DeLuca HF. Is the vitamin d receptor found in muscle? Endocrinology 2011;152: 354-363.
36. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-1527.
37. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr 2008;88: 558S-564S.
38. van der Mei IA, Ponsonby AL, Engelsen O, et al. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 2007;115:1132-1139.
39. Farrell C, Soldo J, Williams P, Herrmann M. 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays. Clin Chem Lab Med 2012;50: 1953-1963.
40. Hsia J, Heiss G, Ren H, et al.; Women's Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007;115:846-854.
41. Avenell A, MacLennan GS, Jenkinson DJ, et al.; RECORD Trial Group. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium(RECORD trial). J Clin Endocrinol Metab 2012;97:614-622.
42. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulinmediated glucose uptake in healthy subjects. Eur J Clin Invest 1997;27:629-633.
43. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic b cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011;94:486-494.